CVS Health Co. (NYSE:CVS) Shares Acquired by Uncommon Cents Investing LLC

Uncommon Cents Investing LLC increased its position in CVS Health Co. (NYSE:CVS) by 6.2% in the fourth quarter, Holdings Channel reports. The firm owned 33,500 shares of the pharmacy operator’s stock after purchasing an additional 1,955 shares during the quarter. Uncommon Cents Investing LLC’s holdings in CVS Health were worth $2,645,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Live Oak Investment Partners acquired a new position in CVS Health in the fourth quarter valued at approximately $25,000. Atticus Wealth Management LLC boosted its stake in CVS Health by 149.0% in the fourth quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock valued at $29,000 after acquiring an additional 219 shares during the period. Cornerstone Planning Group LLC raised its holdings in shares of CVS Health by 111.5% during the third quarter. Cornerstone Planning Group LLC now owns 461 shares of the pharmacy operator’s stock valued at $32,000 after buying an additional 243 shares during the last quarter. PCA Investment Advisory Services Inc. bought a new stake in shares of CVS Health during the second quarter valued at approximately $37,000. Finally, ZRC Wealth Management LLC raised its holdings in shares of CVS Health by 400.0% during the fourth quarter. ZRC Wealth Management LLC now owns 500 shares of the pharmacy operator’s stock valued at $39,000 after buying an additional 400 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on CVS shares. TD Cowen cut their price target on CVS Health from $102.00 to $99.00 and set an “outperform” rating on the stock in a report on Monday, December 11th. Royal Bank of Canada dropped their target price on CVS Health from $86.00 to $84.00 and set an “outperform” rating on the stock in a report on Thursday, February 8th. Leerink Partnrs reissued an “outperform” rating on shares of CVS Health in a report on Monday, February 26th. HSBC initiated coverage on CVS Health in a report on Friday, December 22nd. They set a “buy” rating and a $94.00 target price on the stock. Finally, StockNews.com cut CVS Health from a “buy” rating to a “hold” rating in a report on Thursday, February 15th. Four analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $90.21.

Insider Activity

In other news, EVP Prem S. Shah sold 29,473 shares of the business’s stock in a transaction on Friday, February 16th. The shares were sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the transaction, the executive vice president now directly owns 39,765 shares in the company, valued at approximately $3,059,916.75. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. 0.25% of the stock is currently owned by corporate insiders.

CVS Health Trading Up 0.4 %

NYSE CVS opened at $79.76 on Friday. CVS Health Co. has a twelve month low of $64.41 and a twelve month high of $83.25. The company has a debt-to-equity ratio of 0.77, a quick ratio of 0.63 and a current ratio of 0.86. The stock has a market cap of $100.37 billion, a price-to-earnings ratio of 12.35, a PEG ratio of 1.05 and a beta of 0.51. The firm’s 50 day moving average price is $75.66 and its two-hundred day moving average price is $73.46.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share for the quarter, topping the consensus estimate of $2.01 by $0.11. CVS Health had a net margin of 2.33% and a return on equity of 15.25%. The firm had revenue of $93.81 billion for the quarter, compared to analysts’ expectations of $90.58 billion. During the same period in the previous year, the company posted $1.99 EPS. The company’s quarterly revenue was up 11.9% compared to the same quarter last year. Equities analysts anticipate that CVS Health Co. will post 8.33 EPS for the current year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd will be issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 3.34%. The ex-dividend date of this dividend is Friday, April 19th. CVS Health’s dividend payout ratio is currently 41.18%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.